武田和阿特拉斯都将其研发中心迁至美国。
Takeda and Astellas have both moved their global research and development hub to America.
它的部分经费由吡格列酮的制造商武田制药提供。
It was financed in part by Takeda Pharmaceuticals, maker of pioglitazone.
因此，武田、阿斯特拉和第一三共制药都预期到今年药品的营业利润会骤降。
As a result, Takeda, Astellas and Daiichi Sankyo all expect a steep drop in operating profits this year.
该项研究在周四发表于《新英格兰医学杂志》。它的部分经费由吡格列酮的制造商武田制药提供。
The study was published on Thursday in The New England Journal of Medicine. It was financed in part by Takeda Pharmaceuticals, maker of pioglitazone.
据武田制药公司(成立于1781年)的首席执行官武田长谷川称，有两万多家的日本公司现在至少有100岁了。
According to Yasuchika Hasegawa, chief executive of Takeda Pharmaceuticals (founded in 1781), more than 20, 000 Japanese firms are at least 100 years old.
该研究由生产艾可拓的武田制药赞助。
The study was funded by Takeda Pharmaceuticals, which manufactures Actos.
武田制药(创始于1781年)的首席执行官长谷川闲史(Yasuchika Hasegawa)说，超过两万家日本企业至少有100年的历史。
According to Yasuchika Hasegawa, chief executive of Takeda Pharmaceuticals (founded in 1781), more than 20,000 Japanese firms are at least 100 years old.
武田制药(创始于1781年)的首席执行官长谷川闲史(Yasuchika Hasegawa)说，超过两万家日本企业至少有100年的历史。
According to Yasuchika Hasegawa, chief executive of Takeda Pharmaceuticals (founded in 1781), more than 20,000 Japanese firms are at least 100 years old.
应用推荐